News
Mizuho Securities has upgraded Palantir (NASDAQ:PLTR) from Underperform to Neutral after the company's revenue growth ...
Palantir Technologies (PLTR) has recently forged partnerships with Knightscope Inc. for entry into the U.S. federal marketplace and with Velocity Clinical Research to enhance clinical trial efficiency ...
Felix Wintle, manager of the VT Tyndall North American Fund, highlights three favourite US stocks where he'd put his money ...
6h
Investor's Business Daily on MSNPalantir Hits New High Ahead Of Q2 Earnings ReportPalantir stock on Thursday hit an all-time high ahead of its second quarter earnings report on Aug. 4. Palantir has advanced ...
Goldman Sachs projects a 50% surge in global datacenter demand by 2027 as Meta, Palantir and Amazon ramp up AI infrastructure ...
8h
Barchart on MSNPalantir Stock Keeps Hitting New All-Time HighsPalantir (PLTR) hit a new all-time high of $153.15 in morning trading on July 17. ・PLTR shares have a 100% technical “Buy” signal via Barchart. ・Shares have been red hot in 2025, more than doubling in ...
After all, AI chips used in data centers are equipped with large amounts of high-bandwidth memory (HBM), since they can provide substantially higher bandwidth and lower latency. These properties allow ...
With a strong brand and a mover advantage, the company seems positioned to benefit from the broader AI wave. However, beneath ...
Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer ...
Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company ("Hyperscale Data” or the "Company”), today announced preliminary revenue of $25.8 million for the second quarter of 2025, a ...
Palantir is the biggest gainer in the S&P 500 so far this year. The AI-driven software company’s earnings are soaring amid ...
Mizuho Securities upgraded their rating on Palantir's stock from underperform to neutral due to the company's surge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results